Alzheimer’s disease: a continuum with visual involvements
暂无分享,去创建一个
J. Salazar | R. de Hoz | A. Ramírez | J. Ramírez | M. L. Delgado-Losada | F. Maestú | P. Gil | E. Salobrar-García | I. López-Cuenca | J. Fernández-Albarral | P. Rojas | F. Ramírez-Toraño | Lorena Elvira‐Hurtado | Lídia Sánchez-Puebla | J. A. Matamoros | Mario Salas | Soraya Alfonsín | Inés López-Cuenca | Lorena Elvira-Hurtado | Lidia Sánchez-Puebla
[1] Britta U. Westner,et al. Structural and functional changes in the retina in Parkinson’s disease , 2023, Journal of Neurology, Neurosurgery, and Psychiatry.
[2] J. Kremers,et al. The Association Between Acquired Color Deficiency and PET Imaging of Neurodegeneration in Mild Cognitive Impairment and Alzheimer Disease , 2022, Investigative ophthalmology & visual science.
[3] D. Han,et al. Deficits in color detection in patients with Alzheimer disease , 2022, PloS one.
[4] Chi-Wu Chang,et al. Visual Function and Visual Perception among Senior Citizens with Mild Cognitive Impairment in Taiwan , 2021, Healthcare.
[5] Natalie D. Phillips,et al. Visual Performance and Cortical Atrophy in Vision-Related Brain Regions Differ Between Older Adults with (or at Risk for) Alzheimer's Disease. , 2021, Journal of Alzheimer's disease : JAD.
[6] L. Ferrucci,et al. Association of Vision Impairment With Cognitive Decline Across Multiple Domains in Older Adults , 2021, JAMA network open.
[7] T. Wisniewski,et al. Exploration of Rapid Automatized Naming and Standard Visual Tests in Prodromal Alzheimer Disease Detection , 2021, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.
[8] A. Koyanagi,et al. The association between objective vision impairment and mild cognitive impairment among older adults in low- and middle-income countries , 2021, Aging Clinical and Experimental Research.
[9] J. Salazar,et al. Amyotrophic Lateral Sclerosis: A Neurodegenerative Motor Neuron Disease With Ocular Involvement , 2020, Frontiers in Neuroscience.
[10] Nicole M. Armstrong,et al. Association of Visual Impairment With Risk of Incident Dementia in a Women's Health Initiative Population. , 2020, JAMA ophthalmology.
[11] 2020 Alzheimer's disease facts and figures , 2020, Alzheimer's & dementia : the journal of the Alzheimer's Association.
[12] Eileen F. Tallman,et al. Visual contrast sensitivity is associated with the presence of cerebral amyloid and tau deposition , 2020, Brain communications.
[13] A. Ferreras,et al. Ocular Involvement in Friedreich Ataxia Patients and Its Relationship with Neurological Disability, a Follow-Up Study , 2020, Diagnostics.
[14] J. Salazar,et al. Changes in visual function and retinal structure in the progression of Alzheimer's disease , 2019, PloS one.
[15] H. Amièva,et al. Vision loss and 12-year risk of dementia in older adults: the 3C cohort study , 2019, European Journal of Epidemiology.
[16] K. Yaffe,et al. Multiple Sensory Impairment Is Associated With Increased Risk of Dementia Among Black and White Older Adults. , 2018, The journals of gerontology. Series A, Biological sciences and medical sciences.
[17] M. Albert,et al. Vision Impairment and Cognitive Outcomes in Older Adults: The Health ABC Study. , 2018, The journals of gerontology. Series A, Biological sciences and medical sciences.
[18] R. González-Reyes,et al. Visual Features in Alzheimer's Disease: From Basic Mechanisms to Clinical Overview , 2018, Neural plasticity.
[19] Jesus Pintor,et al. Ocular Manifestations of Alzheimer's and Other Neurodegenerative Diseases: The Prospect of the Eye as a Tool for the Early Diagnosis of Alzheimer's Disease , 2018, Journal of Ophthalmology.
[20] K. Yaffe,et al. Reduced contrast sensitivity among older women is associated with increased risk of cognitive impairment , 2018, Annals of neurology.
[21] Keith L Black,et al. Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer's disease. , 2017, JCI insight.
[22] A. Sanford. Mild Cognitive Impairment. , 2017, Clinics in geriatric medicine.
[23] J. Salazar,et al. The Role of Microglia in Retinal Neurodegeneration: Alzheimer's Disease, Parkinson, and Glaucoma , 2017, Front. Aging Neurosci..
[24] Mark S. Bolding,et al. Retinal changes in the Tg-SwDI mouse model of Alzheimer’s disease , 2017, Neuroscience.
[25] R. Klein,et al. Age‐Related Sensory Impairments and Risk of Cognitive Impairment , 2016, Journal of the American Geriatrics Society.
[26] Brian Barton,et al. Changes in Visual Cortex in Healthy Aging and Dementia , 2016 .
[27] V. Polo,et al. Visual dysfunction and its correlation with retinal changes in patients with Alzheimer's disease , 2017, Eye.
[28] Arthur Konnerth,et al. Impairments of neural circuit function in Alzheimer's disease , 2016, Philosophical Transactions of the Royal Society B: Biological Sciences.
[29] A. Pelletier,et al. Vision Loss in Older Adults. , 2016, American family physician.
[30] J. Cunha,et al. Alzheimer’s disease: A review of its visual system neuropathology. Optical coherence tomography—a potential role as a study tool in vivo , 2016, Graefe's Archive for Clinical and Experimental Ophthalmology.
[31] T. H. Ferreira-Vieira,et al. Alzheimer's Disease: Targeting the Cholinergic System , 2016, Current neuropharmacology.
[32] J. Salazar,et al. Ophthalmologic Psychophysical Tests Support OCT Findings in Mild Alzheimer's Disease , 2015, Journal of ophthalmology.
[33] J. Salazar,et al. Macular thickness as a potential biomarker of mild Alzheimer's disease. , 2014, Ophthalmology.
[34] Tamiko R. MaGee,et al. Visual contrast sensitivity in Alzheimer’s disease, mild cognitive impairment, and older adults with cognitive complaints , 2013, Neurobiology of Aging.
[35] Y. Glovinsky,et al. Comparison between Hardy–Rand–Rittler 4th edition and Ishihara color plate tests for detection of dyschromatopsia in optic neuropathy , 2013, Graefe's Archive for Clinical and Experimental Ophthalmology.
[36] Denise C. Park,et al. Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[37] J. Morris,et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[38] Arne D. Ekstrom,et al. Family history of Alzheimer's disease and hippocampal structure in healthy people. , 2010, The American journal of psychiatry.
[39] P. Orsini,et al. Dysfunction of the magnocellular stream in Alzheimer's disease evaluated by pattern electroretinograms and visual evoked potentials , 2010, Brain Research Bulletin.
[40] Isidro Ferrer,et al. Diminished Perisomatic GABAergic Terminals on Cortical Neurons Adjacent to Amyloid Plaques , 2009, Front. Neuroanat..
[41] Jen‐Hau Chen,et al. Risk factors for dementia. , 2009, Journal of the Formosan Medical Association = Taiwan yi zhi.
[42] C. Caltagirone,et al. Color Discrimination Performance in Patients with Alzheimer’s Disease , 2009, Dementia and Geriatric Cognitive Disorders.
[43] Grover C. Gilmore,et al. Enhanced Stimulus Strength Improves Visual Cognition in Aging and Alzheimer's Disease , 2007, Cortex.
[44] T. Arendt,et al. The significance of the cholinergic system in the brain during aging and in Alzheimer’s disease , 2006, Journal of Neural Transmission.
[45] M. Arguin,et al. Establishing visual category boundaries between objects: A PET study , 2005, Brain and Cognition.
[46] Laura Fratiglioni,et al. APOE genotype, family history of dementia, and Alzheimer disease risk: a 6-year follow-up study. , 2004, Archives of neurology.
[47] T. Bekinschtein,et al. White matter hyperintensities are significantly associated with cortical atrophy in Alzheimer’s disease , 2004, Journal of Neurology, Neurosurgery & Psychiatry.
[48] A. Wirz-Justice,et al. Colour vision deficiencies in Alzheimer's disease. , 2003, Age and ageing.
[49] M. Bar. A Cortical Mechanism for Triggering Top-Down Facilitation in Visual Object Recognition , 2003, Journal of Cognitive Neuroscience.
[50] A. Wirz-Justice,et al. Distribution of Melatonin MT1 Receptor Immunoreactivity in Human Retina , 2002, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[51] Howard Chertkow,et al. Word-Reading Thresholds in Alzheimer Disease and Mild Memory Loss: A Pilot Study , 2002, Alzheimer disease and associated disorders.
[52] E K Warrington,et al. A disorder of colour perception associated with abnormal colour after-images: a defect of the primary visual cortex , 2001, Journal of neurology, neurosurgery, and psychiatry.
[53] M. Rizzo,et al. Perception of movement and shape in Alzheimer's disease. , 1998, Brain : a journal of neurology.
[54] Walter G. Sannita,et al. Cholinergic modulation, visual function and Alzheimer's dementia , 1997, Vision Research.
[55] Paul R. Martin,et al. Evidence that Blue‐on Cells are Part of the Third Geniculocortical Pathway in Primates , 1997, The European journal of neuroscience.
[56] Sandra E. Black,et al. Focal Cortical Atrophy Syndromes , 1996, Brain and Cognition.
[57] M. Dick,et al. Vision in dementia: contrast effects. , 1996, Neurological research.
[58] S. Corkin,et al. Visual dysfunction predicts cognitive deficits in Alzheimer's disease. , 1995, Optometry and vision science : official publication of the American Academy of Optometry.
[59] P J Whitehouse,et al. Contrast sensitivity in Alzheimer's disease: a 1-year longitudinal analysis. , 1995, Optometry and vision science : official publication of the American Academy of Optometry.
[60] J. Elias,et al. Contrast sensitivity dysfunction in Alzheimer's disease , 1993, Neurology.
[61] D. Levine,et al. The visual variant of Alzheimer's disease , 1993, Neurology.
[62] R. Mayeux,et al. Risk of dementia in first-degree relatives of patients with Alzheimer's disease and related disorders. , 1991, Archives of neurology.
[63] Alfredo A. Sadun,et al. Retinal ganglion cell degeneration in Alzheimer's disease , 1989, Brain Research.
[64] D B Elliott,et al. CONTRAST SENSITIVITY DECLINE WITH AGEING: A NEURAL OR OPTICAL PHENOMENON? * , 1987, Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians.
[65] M. Borchert,et al. Assessment of visual impairment in patients with Alzheimer's disease. , 1987, American journal of ophthalmology.
[66] M J Campbell,et al. Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: a quantitative study of visual and auditory cortices , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[67] A. Bron,et al. Effect of age on contrast sensitivity function: uniocular and binocular findings. , 1985, The British journal of ophthalmology.
[68] M. Moscovitch,et al. Visual processing deficits as assessed by spatial frequency contrast sensitivity and backward masking in normal ageing and Alzheimer's disease. , 1984, Brain : a journal of neurology.
[69] L. Walker. Aβ Plaques. , 2020, Free neuropathology.
[70] V. Jindal. Interconnection Between Brain and Retinal Neurodegenerations , 2014, Molecular Neurobiology.
[71] R. Liutkeviciene,et al. Associations between contrast sensitivity and aging. , 2013, Medicina.
[72] J. Molinuevo,et al. [Perception Digital Test (PDT) for the assessment of incipient visual disorder in initial Alzheimer's disease]. , 2007, Neurologia.
[73] A. Cronin-Golomb,et al. The impact of acuity on performance of four clinical measures of contrast sensitivity in Alzheimer's disease. , 2003, The journals of gerontology. Series B, Psychological sciences and social sciences.
[74] M. Mendez,et al. Optometric management of patients with Alzheimer's disease. , 1997, Journal of the American Optometric Association.